HOME >> BIOLOGY >> NEWS
Multiple lifestyle changes effectively lower blood pressure

el and colleagues followed 810 adults with elevated blood pressure at four clinical centers: Johns Hopkins; Pennington Biomedical Research Center, Baton Rouge, La.; Duke University Medical Center, Durham, N.C.; and Kaiser Permanente Center for Health Research, Portland, Ore. The average age of participants was 50. Sixty-two percent were women and 34 percent were African-American. Overall, the participants were overweight and sedentary.

PREMIER participants were assigned randomly to one of three groups. The first group had one 30-minute session with a registered dietitian offering general advice on lowering blood pressure. The second group had 18 counseling sessions over the six-month period on losing weight, reducing salt and increasing exercise but no advice on the DASH diet. A third group also had 18 sessions, but the counseling included advice on the DASH diet (as well as the counseling on exercise, weight loss and salt reduction). Those in the groups with 18 counseling sessions kept track of their physical activity and food intake.

While members of all three groups lowered blood pressure, the third group had the best results. Those in this group doubled the reduction in blood pressure compared with those in the group that received one session. The third group also was much less likely to need blood pressure medications. By six months, 19 people in the one-session group needed blood pressure drugs, compared with two people in the second group and five people in the third group.

Appel acknowledges that adopting multiple changes can sometimes be a challenge. "For people who have a hard time with this, start with one change, like exercising, and then add others as you can." Before starting or increasing their exercise, people should check with their physician, he says.

The study was supported by the National Heart, Lung and Blood Institute. Appel chaired the writing group; his co-authors were Catherine M. Champagne, Ph.D
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
22-Apr-2003


Page: 1 2 3

Related biology news :

1. A new discovery by scientists at the MNI may provide insights into Multiple Sclerosis
2. Multiple factors affect flight power curves among species
3. Multiple births - their risks and how to prevent them
4. Multiple studies show that psyllium lowers cholesterol
5. Multiple Chemical Sensitivity: A 1999 consensus
6. Researcher Awarded Patent For System To Fight Multiple Diseases
7. Scientists Find Multiple New Uses For Worn-Out Tires
8. Relapses Prevented In Mouse Model Of Multiple Sclerosis: Research Aimed At Treating Relapses In Human MS
9. Protein Implicated In Multiple Sclerosis
10. Discovery By Fertility Specialist Offers Promise Of Reducing Multiple BirthsTied To Fertility Treatment
11. Common Cold Caused By Multiple Viruses

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Multiple lifestyle changes effectively lower blood pressure

(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... YORK , June 30, 2015 To bolster ... security provider HYPR Corp. announced today the addition of two ... will serve as board advisor and David Raviv ... the team underscore HYPR Corp.,s commitment to providing the most ... Dimitri Sirota co-founded Layer 7 Technologies, a provider ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: